Flin Flon, Manitoba – June 10, 2025 – Canadian Gold Corp. (“Canadian Gold” or the “Company”) (TSX-V: CGC) is pleased to announce ongoing drill results from its Phase 4 drill program at the 100%-owned Tartan […]
Toronto, Ontario–(Newsfile Corp. – June 3, 2025) – Pasofino Gold Limited (TSXV: VEIN) (OTCQB: EFRGF) (FSE: N07A) (“Pasofino” or the “Company“) provides a corporate update on its activities at the Dugbe Gold Project (“Dugbe“) in […]
South Zone Now 310m (120%) Below 2017 Resource Flin Flon, Manitoba–(Newsfile Corp. – May 12, 2025) – Canadian Gold Corp. (TSXV: CGC) (“Canadian Gold” or the “Company”) is pleased to announce ongoing drill results from […]
IRVINE, CA / ACCESS Newswire / May 1, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2025 third quarter ended March 31, 2025. The Company also filed its Quarterly Report on Form 10-Q for […]
Toronto, Ontario–(Newsfile Corp. – April 30, 2025) – Pasofino Gold Limited (TSXV: VEIN) (FSE: N07A) (“Pasofino” or the “Company“) is pleased to announce a non-brokered private placement of units (each, a “Unit“) at C$0.50 (or […]
Interim Results from FDA-Funded Study Reinforces HyBryte’s™ Rapid Response and Strong Safety Profile PRINCETON, N.J., April 14, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat […]
Flin Flon, Manitoba–(Newsfile Corp. – April 10, 2025) – Canadian Gold Corp. (TSXV: CGC) (“Canadian Gold” or the “Company“) is pleased to announce its plans to double the size of its Phase 4 drill program […]
VANCOUVER & DALLAS, April 10, 2025–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of Robert Wills, […]
Broader protection induced by combination of COVID adenovirus vaccine plus CiVax™ compared to 2-shot mRNA vaccination series PRINCETON, N.J., March 25, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on […]
Conference Call Scheduled for March 31, 2025 4:30pm ET VANCOUVER, British Columbia & DALLAS, March 19, 2025–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com